Background Candida auris is an emerging multidrug‐resistant pathogen in intensive care
settings (ICU). During the coronavirus disease 19 (COVID‐19) pandemic, ICU admissions …

The incidence of COVID-19-associated candidiasis (CAC) is increasing, resulting in a grave
outcome among hospitalized patients with COVID-19. The most alarming condition is the …

Abstract Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by
SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections …

Since its first emergence in December 2019, due to its fast distribution throughout the world,
SARS-COV-2 become a global concern. With the extremely increased number of …

Staphylococcus haemolyticus, a key species of the Staphylococcus genus, holds significant
importance in healthcare-associated infections, due to its notable resistance to …

Candida auris is an opportunistic human pathogen that has rapidly spread to multiple
countries and continents and has been associated with a high number of nosocomial …

Candida auris has drawn global attention due to its alarming multidrug resistance and the
emergence of pan resistant strains. C. auris poses a significant risk in nosocomial …

The emergent fungal pathogen Candida auris is increasingly recognised as an important
cause of healthcare-associated infections globally. It is highly transmissible, adaptable, and …

Abstract Purpose of Review This review discusses the connections between the gut-lung
axis, gut and respiratory tract dysbiosis, and Candida bloodstream, oral, and respiratory …

Methods In order to identify any recent updates in relation to C. auris since a previous review
of the literature, a search of articles was conducted, between 2019 and 2023, with …